CRP and micro-albumin: New markers of cardiovascular risk in type 2 diabetes;CRP et micro-albuminurie: Nouveaux marqueurs du risque cardiovasculaire chez les diabétiques de type 2

Annales de Cardiologie et d'Angeiologie

Volumn 60, Issue 4, 2011, Pages 207-210

  El Oudi, M ^a   Aouni, Z ^a   Ouertani, H ^a   Mazigh, C ^a   Nsiri, B ^a   Zidi, B ^a   Machghoul, S ^a  

^a MILITARY HOSPITAL OF TUNIS   (Tunisia)

Author keywords

C reactive protein; Micro albumin; Type 2 diabetes; Vascular complications

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; HUMAN; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN ANALYSIS; ALBUMINURIA; CARDIOVASCULAR DISEASE; FEMALE; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR;

ALBUMINURIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 80052908024     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2010.12.026     Document Type: Article

References (17)

1. Boullu-Sanchis S., Kessler L.P. Le diabète de type 2: données épidémiologiques récentes. Feuill Biol 1999, 229:55-57.
2. Raccach D., Blandine J.D., Vague P. Diabète non insulinodépendant. Rev Prat 1999, 49:629-634.
3. Donelly R. La micro-albuminurie, objectif thérapeutique chez les diabétiques de type 2. Presse Med 2002, 31:9-12.
4. Mahe I., Bergmann J.F. Le risque cardiovasculaire multifactoriel. Presse Med 2000, 29:47-54.
5. Raynaud E., Brun J.F., Fedou C., Puech-Cathala A.M., Perez Martin A., Orsetti A. La micro-albuminurie marqueur précoce d'atteinte rénale, est-elle aussi un facteur de risque cardiovasculaire. Ann Biol Clin 1998, 56:671-679.
6. Ettinger L.M., Freeman K., DiMartino-Nardi J.R., Flynn J.T. Microalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus. J Pediatr 2005, 147:67-73.
7. Weir M.R. Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor. J Clin Hypertens 2004, 6(3):134-141.
8. Matsui J., Tamasawa N., Tanabe J., Kasai N., Murakami H., et al. LDL particle size and lipid. Compositions are risk factor for microalbuminuria in normotensive and normocholesterolemic patients with type 2 diabetes. Diabetes Res Clin Pract 2004, 66:229-236.
9. Bohm M., Thoenes M., Danchin N., Bramlage P., La Puerta P., Volpe M. Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: thei-SEARCH global study. J Hypertens 2007, 25:2317-2324.
10. Gustavsson C.G., Agardh C.D. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1C within the normal range. Eurp Heart J 2004, 25:2120-2124.
11. King D.E., MainousThomas A.G., et al. C-reactive protein and glycemic control in adults with Diabetes. Diabetes care 2003, 26:1535-1539.
12. Lagrand W.K., Visser C.A., Willem T., et al. C-reactive protein as a cardiovascular disease risk factor more than an epiphenomenom. Circulation 1999, 100:96-102.
13. Aouni Z., Oudi M., Ourtani H., Mazigh C., Essaies O., Nsiri B., et al. Inflammation chronique subclinique et insulinorésistance chez les diabétiques non Insulinodépendants. Immunoanal Biol Spec 2008, 23:353-357.
14. Nakamura M., Onoda T., Itai K., Ohsawa M., Satou K., Sakai T., et al. Association between serum C-reactive protein levels and microalbuminuria: a population based cross-sectional study in northern Iwate, Japan. Intern Med 2004, 43:919-925.
15. Frank B., Hu, James B., Meigs, Tricia Y., et al. Inflammatory markers and risk of developping type 2 diabetes in women. Diabetes 2004, 53:693-700.
16. Ming-hui G., Jie H., An-kang L., Ying C., Wei-feng S., Xiao-ying L., et al. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in chinese coronary artery disease patients with different glucose tolerance status. Chin Med J 2008, 121:2509-2516.
17. Andreas Festa, Ralph D'Agostino, George Howard, Leena Mykkänen, Russell P., Tracy, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102:42-47.